Herpes Simplex Virus Type 1 & 2
Use
The qualitative real-time PCR assay is designed for the detection of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). HSV-1 is typically linked to oral lesions, whereas HSV-2 is often associated with genital lesions. However, both types can infect either area, highlighting the importance of accurate detection for appropriate diagnosis and treatment in anogenital and central nervous system infections.
Special Instructions
Specimens should be collected as follows: Cervical cells in ThinPrep PAP solution or SurePath Test Pack solution; Swab from lesion in viral transport media; Fresh or frozen tissue should be 5 mm3; CSF should be in a sterile container, with a volume of 2.0 mL (min. 1.0 mL), and should not be diluted.
Limitations
This test is intended for research use only and not for human diagnostic use. It should be noted that test results can be affected by factors such as improper specimen collection, handling, transport, or insufficient quantity. The accuracy of test results is also contingent upon the integrity of the specimen, and deviations from specified conditions or procedures may affect outcomes.
Methodology
PCR-based (RT-PCR)
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Cervical Swab
Volume
2.0 mL
Minimum Volume
1.0 mL
Container
ThinPrep PAP solution or SurePath Test Pack solution
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 18-25°C, ambient |
| Refrigerated | 2-8°C, stable 96 hours |
| Frozen | ≤ -15°C |